Brief: Aequus Receives Approval For New Lubricating Eye Drops In Canada
Oct 29 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* AEQUUS RECEIVES APPROVAL FOR NEW ‘EVOLVE - DAILY
INTENSIVE’
LUBRICATING EYE DROPS IN CANADA
Source text for Eikon: ID:nGNX1p5hGF
Further company coverage: AQS.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange